Jiwen Chen, Ph D, RAC, is an expert in cell and gene therapy regulatory affairs, manufacturing, and analytical characterization. He has held positions in Bristol Myers Squibb and two biotech companies with increasing responsibilities, and has contributed to the development of several medicines currently on the market. He obtained his doctoral degree from the University of Nebraska.